bioRxivSynthetic BiologyPreprint
speedingCARs: accelerating the engineering of CAR T cells by signaling domain shuffling and single-cell sequencing
Raphaël B. Di RobertoiD, Rocío Castellanos-RuedaiD, Fabrice S. SchlatteriD, Darya PalianinaiD, Oanh T. P. NguyeniD, Edo KapetanoviciD, Andreas R. HierlemanniD, Nina KhannaiD, Sai T. ReddyiD
Abstract
Chimeric antigen receptors (CARs) consist of an extracellular antigen-binding region fused to intracellular signaling domains, thus enabling customized T cell responses against target cells. Due to the low-throughput process of systematically designing and functionally testing CARs, only a small set of immune signaling domains have been thoroughly explored, despite their major role in T cell activation, effector function and persistence. Here, we present speedingCARs, an integrated method for engineering CAR T cells by signaling domain shuffling and functional screening by single-cell sequencing. Leveraging the inherent modularity of natural signaling domains, we generated a diverse library of 180 unique CAR variants, which were genomically integrated into primary human T cells by CRISPR-Cas9. Functional and pooled screening of the CAR T cell library was performed by co-culture with tumor cells, followed by single-cell RNA sequencing (scRNA-seq) and single-cell CAR sequencing (scCAR-seq), thus enabling high-throughput profiling of multi-dimensional cellular responses. This led to the discovery of several CAR variants that retained the ability to kill tumor cells, while also displaying diverse transcriptional signatures and T cell phenotypes. In summary, speedingCARs substantially expands and characterizes the signaling domain combinations suited for CAR design and supports the engineering of next-generation T cell therapies.
- organism: human
- assay: scRNA-seq
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
- Citations
- 4
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A functional screening platform for engineering chimeric antigen receptors with reduced on-target, off-tumour activation
R. B. Di Roberto, R. C. Rueda, … S. T. Reddy·bioRxiv·Apr 30, 2020
- CARPOOL: A library-based platform to rapidly identify next generation chimeric antigen receptors
T. Kyung, K. S. Gordon, … M. E. Birnbaum·bioRxiv·Jul 9, 2021
- Dissecting the role of CAR signaling architectures on T cell activation and persistence using pooled screening and single-cell sequencing
Rocío Castellanos-Rueda, Kai-Ling K. Wang, … Sai T. Reddy·bioRxiv·Feb 26, 2024
- Pooled screening of CAR T cells identifies non-native signaling domains for next- generation immunotherapies
D. B. Goodman, C. S. Azimi, … K. Roybal·bioRxiv·Jul 11, 2021
- A practical workflow for CAR screening in primary T cells using fitness-guided design and mRNA electroporation
Atsushi Okuma, Yoshihito Ishida, Shoji Hisada·bioRxiv·Jul 29, 2026
- Rational Tuning of CAR Tonic Signaling Yields Superior T-Cell Therapy for Cancer
X. Chen, M. Khericha, … Y. Y. Chen·bioRxiv·Oct 1, 2020